KEGG   DRUG: EfalizumabHelp
Entry
D03959                      Drug                                   

Name
Efalizumab (USAN/INN);
Raptiva (TN)
Remark
ATC code: 
Chemical group: 
Efficacy
Antipsoriatic, Immunosuppressant, Anti-CD11a antibody
Comment
Monoclonal antibody
Treatment of transplant rejections
Target
  Pathway
Cell adhesion molecules (CAMs)
Natural killer cell mediated cytotoxicity
Leukocyte transendothelial migration
Regulation of actin cytoskeleton
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AA Selective immunosuppressants
     L04AA21 Efalizumab
      D03959  Efalizumab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Others
  Cellular antigens
   CD11a
    Efalizumab
     D03959  Efalizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
214745-43-4
PubChem: 
DrugBank: 

» Japanese version   » Back

DBGET integrated database retrieval system